Suppr超能文献

通过与 B 结构域肽互补恢复因子 Va 样变体的辅因子状态。

Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides.

机构信息

From the Division of Hematology, The Children's Hospital of Philadelphia and.

From the Division of Hematology, The Children's Hospital of Philadelphia and; the Department of Pediatrics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania 19104.

出版信息

J Biol Chem. 2013 Oct 18;288(42):30151-30160. doi: 10.1074/jbc.M113.506840. Epub 2013 Sep 6.

Abstract

Coagulation factor V (FV) circulates as an inactive procofactor and is activated to FVa by proteolytic removal of a large inhibitory B-domain. Conserved basic and acidic sequences within the B-domain appear to play an important role in keeping FV as an inactive procofactor. Here, we utilized recombinant B-domain fragments to elucidate the mechanism of this FV autoinhibition. We show that a fragment encoding the basic region (BR) of the B-domain binds with high affinity to cofactor-like FV(a) variants that harbor an intact acidic region. Furthermore, the BR inhibits procoagulant function of the variants, thereby restoring the procofactor state. The BR competes with FXa for binding to FV(a), and limited proteolysis of the B-domain, specifically at Arg(1545), ablates BR binding to promote high affinity association between FVa and FXa. These results provide new insight into the mechanism by which the B-domain stabilizes FV as an inactive procofactor and reveal how limited proteolysis of FV progressively destabilizes key regulatory regions of the B-domain to produce an active form of the molecule.

摘要

凝血因子 V(FV)以无活性的前体形式循环,并通过蛋白水解去除大的抑制性 B 结构域而被激活为 FVa。B 结构域内保守的碱性和酸性序列似乎在维持 FV 作为无活性前体方面发挥着重要作用。在这里,我们利用重组 B 结构域片段来阐明这种 FV 自身抑制的机制。我们表明,编码 B 结构域碱性区域(BR)的片段与具有完整酸性区域的辅因子样 FV(a)变体以高亲和力结合。此外,BR 抑制变体的促凝功能,从而恢复前体状态。BR 与 FXa 竞争与 FV(a)结合,并且 B 结构域的有限蛋白水解,特别是在 Arg(1545)处,使 BR 结合失活,促进 FVa 和 FXa 之间高亲和力的结合。这些结果为 B 结构域如何稳定 FV 作为无活性前体提供了新的见解,并揭示了 FV 的有限蛋白水解如何逐渐破坏 B 结构域的关键调节区域,从而产生该分子的活性形式。

相似文献

1
Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides.
J Biol Chem. 2013 Oct 18;288(42):30151-30160. doi: 10.1074/jbc.M113.506840. Epub 2013 Sep 6.
2
Regulation of factor V and factor V-short by TFPIα: Relationship between B-domain proteolysis and binding.
J Biol Chem. 2021 Jan-Jun;296:100234. doi: 10.1074/jbc.RA120.016341. Epub 2021 Jan 7.
3
Factor Va-factor Xa interactions: molecular sites involved in enzyme:cofactor assembly.
Scand J Clin Lab Invest Suppl. 2002;237:5-11. doi: 10.1080/003655102762377439.
4
Regulation of factor V by the anticoagulant protease activated protein C: Influence of the B-domain and TFPIα.
J Biol Chem. 2022 Nov;298(11):102558. doi: 10.1016/j.jbc.2022.102558. Epub 2022 Sep 30.
5
Amino acid region 1000-1008 of factor V is a dynamic regulator for the emergence of procoagulant activity.
J Biol Chem. 2013 Dec 27;288(52):37026-38. doi: 10.1074/jbc.M113.462374. Epub 2013 Oct 31.
6
Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site.
J Biol Chem. 2007 Jul 27;282(30):21848-55. doi: 10.1074/jbc.M702192200. Epub 2007 Jun 6.
7
A bipartite autoinhibitory region within the B-domain suppresses function in factor V.
J Biol Chem. 2012 Jul 27;287(31):26342-51. doi: 10.1074/jbc.M112.377168. Epub 2012 Jun 15.
9
Proposed structural models of the prothrombinase (FXa-FVa) complex.
Proteins. 2006 May 15;63(3):440-50. doi: 10.1002/prot.20848.
10
Notecarin D binds human factor V and factor Va with high affinity in the absence of membranes.
J Biol Chem. 2011 Nov 4;286(44):38286-38297. doi: 10.1074/jbc.M111.247122. Epub 2011 Sep 12.

引用本文的文献

2
Cryo-EM structure of the prothrombin-prothrombinase complex.
Blood. 2022 Jun 16;139(24):3463-3473. doi: 10.1182/blood.2022015807.
4
Generation of an anticoagulant aptamer that targets factor V/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples.
Cell Chem Biol. 2022 Feb 17;29(2):215-225.e5. doi: 10.1016/j.chembiol.2022.01.009. Epub 2022 Feb 2.
5
Factor V east Texas variant causes bleeding in a three-generation family.
J Thromb Haemost. 2022 Mar;20(3):565-573. doi: 10.1111/jth.15612. Epub 2021 Dec 7.
6
F5-Atlanta: Factor V-short strikes again.
J Thromb Haemost. 2021 Jul;19(7):1638-1640. doi: 10.1111/jth.15351.
7
Cryo-EM structures of human coagulation factors V and Va.
Blood. 2021 Jun 3;137(22):3137-3144. doi: 10.1182/blood.2021010684.
8
Regulation of factor V and factor V-short by TFPIα: Relationship between B-domain proteolysis and binding.
J Biol Chem. 2021 Jan-Jun;296:100234. doi: 10.1074/jbc.RA120.016341. Epub 2021 Jan 7.
9
Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding.
J Thromb Haemost. 2019 Aug;17(8):1229-1239. doi: 10.1111/jth.14487. Epub 2019 Jun 17.
10
Occlusion of anion-binding exosite 2 in meizothrombin explains its impaired ability to activate factor V.
J Biol Chem. 2019 Feb 15;294(7):2422-2435. doi: 10.1074/jbc.RA118.006510. Epub 2018 Dec 21.

本文引用的文献

1
The C-terminus of tissue factor pathway inhibitor α is required for its interaction with factors V and Va.
J Thromb Haemost. 2012 Sep;10(9):1944-6. doi: 10.1111/j.1538-7836.2012.04834.x.
2
A bipartite autoinhibitory region within the B-domain suppresses function in factor V.
J Biol Chem. 2012 Jul 27;287(31):26342-51. doi: 10.1074/jbc.M112.377168. Epub 2012 Jun 15.
3
Tissue factor pathway inhibitor: structure-function.
Front Biosci (Landmark Ed). 2012 Jan 1;17(1):262-80. doi: 10.2741/3926.
4
Alternatively spliced tissue factor pathway inhibitor: functional implications.
Front Biosci (Schol Ed). 2011 Jun 1;3(4):1457-62. doi: 10.2741/236.
5
Polyphosphate exerts differential effects on blood clotting, depending on polymer size.
Blood. 2010 Nov 18;116(20):4353-9. doi: 10.1182/blood-2010-01-266791. Epub 2010 Aug 13.
6
An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase.
J Biol Chem. 2010 Feb 19;285(8):5212-23. doi: 10.1074/jbc.M109.049833. Epub 2009 Dec 18.
8
The molecular basis of factor V and VIII procofactor activation.
J Thromb Haemost. 2009 Dec;7(12):1951-61. doi: 10.1111/j.1538-7836.2009.03622.x. Epub 2009 Sep 18.
9
Polyphosphate and omptins: novel bacterial procoagulant agents.
J Cell Mol Med. 2009 Oct;13(10):4146-53. doi: 10.1111/j.1582-4934.2009.00884.x. Epub 2009 Sep 1.
10
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency.
Blood. 2008 Nov 1;112(9):3615-23. doi: 10.1182/blood-2008-06-162453. Epub 2008 Aug 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验